• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Shree Ganesh Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540737
INE414Y01015
126.9843008
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
49.92
886.89
EPS(TTM)
Face Value()
Div & Yield %
13.84
10
0
 

India Glycols consolidated net profit rises 35.71% in the March 2026 quarter
May 15,2026
Net profit of India Glycols rose 35.71% to Rs 86.88 crore in the quarter ended March 2026 as against Rs 64.02 crore during the previous quarter ended March 2025. Sales rose 13.11% to Rs 976.35 crore in the quarter ended March 2026 as against Rs 863.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.78% to Rs 292.76 crore in the year ended March 2026 as against Rs 230.92 crore during the previous year ended March 2025. Sales rose 11.76% to Rs 4211.41 crore in the year ended March 2026 as against Rs 3768.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales976.35863.22 13 4211.413768.26 12
OPM %17.0516.91 -15.4213.56 -
PBDT153.69114.38 34 533.42407.52 31
PBT112.4681.79 37 378.04292.32 29
NP86.8864.02 36 292.76230.92 27